- Home
- LSF vs SER Comparison
LSF vs SER Comparison
Compare LSF & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSF
- SER
- Stock Information
- Founded
- LSF 2015
- SER 2017
- Country
- LSF United States
- SER United States
- Employees
- LSF N/A
- SER N/A
- Industry
- LSF Packaged Foods
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- LSF Consumer Staples
- SER Health Care
- Exchange
- LSF Nasdaq
- SER Nasdaq
- Market Cap
- LSF 65.5M
- SER 56.5M
- IPO Year
- LSF 2020
- SER 2018
- Fundamental
- Price
- LSF $6.35
- SER $5.94
- Analyst Decision
- LSF Strong Buy
- SER Strong Buy
- Analyst Count
- LSF 2
- SER 1
- Target Price
- LSF $12.00
- SER $11.00
- AVG Volume (30 Days)
- LSF 26.2K
- SER 16.6K
- Earning Date
- LSF 08-06-2025
- SER 08-08-2025
- Dividend Yield
- LSF N/A
- SER N/A
- EPS Growth
- LSF N/A
- SER N/A
- EPS
- LSF N/A
- SER N/A
- Revenue
- LSF $45,040,358.00
- SER $51,000.00
- Revenue This Year
- LSF $23.40
- SER N/A
- Revenue Next Year
- LSF $20.11
- SER N/A
- P/E Ratio
- LSF N/A
- SER N/A
- Revenue Growth
- LSF 25.04
- SER N/A
- 52 Week Low
- LSF $3.40
- SER $3.81
- 52 Week High
- LSF $10.90
- SER $11.57
- Technical
- Relative Strength Index (RSI)
- LSF 48.20
- SER 51.18
- Support Level
- LSF $6.03
- SER $5.50
- Resistance Level
- LSF $6.74
- SER $6.36
- Average True Range (ATR)
- LSF 0.37
- SER 0.43
- MACD
- LSF 0.01
- SER 0.01
- Stochastic Oscillator
- LSF 53.33
- SER 63.82
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.